Quarterly report pursuant to Section 13 or 15(d)

Common Shares, Warrants and Options (Detail Narrative)

v3.23.2
Common Shares, Warrants and Options (Detail Narrative) - USD ($)
 9 Months Ended 12 Months Ended
May 31, 2023
May 31, 2022
Aug. 31, 2022
Sale average price $ 3.30    
Number of stock options, granted 510,433    
Exercise price $ 2.11   $ 4.21
Description of incentives plan The Company has established an Equity Incentive Plan which currently allows the board of directors to grant up to 510,433 stock options to directors, officers, employees, and consultants. On May 9, 2023, at its annual shareholder meeting, the Company’s shareholders approved amendments to the Equity Incentive Plan, whereby the board of directors were authorized to grant up to 809,165 stock options to directors, officers, employees, and consultants with such amount being adjusted on January 1 each year commencing January 1, 2024, pursuant to an evergreen formula, to be equal to up to 10% of the issued share capital on December 31 of the previous year    
Stock based compensation expense $ 160,748 $ 519,718  
Unrecognized non-cash compensation costs $ 39,117    
Sale of common shares 34,652    
Net proceeds from sale of common shares $ 111,021    
Non-vested stock options 11,750    
Options repricing 267,969    
Compensation expense for options repricing $ 25,194    
Option strike price $ 3.27    
Weighted Average Remaining Contractual Life 9 months 25 days    
Warrants      
Number of Warrants exercisable 2,106,000    
Number of Warrants sold 2,106,000    
Sale price per share $ 0.95    
Weighted Average Remaining Contractual Life 5 years    
Stock Options      
Exercise price repriced $ 3.00    
Options repricing 267,969    
Stock Options | Minimum      
Exercise price $ 9.60    
Stock Options | Maximum      
Exercise price $ 4.80